Composition
Inj: Per ml: beractant contains 25 mg of phospholipids; 8 ml (200 mg phospholipids) vial.
Indications & Dosage
Prophylaxis & treatment of neonatal respiratory distress syndrome (RDS) (hyaline membrane disease) in premature infants: For Intratracheal administration only, ee literature.